Application du SPR dans le criblage des ligands synthétiques du CD36 et sa validation
CD36 is a class B scavenger receptor expressed at the cell surface of macrophages, endothelial cells and platelets, among others. This multiligand receptor is implicated in various diseases such as atherosclerosis, angiogenesis and malaria through the specific binding of ligands, such as oxidized low-density lipoproteins, thrombospondin-1 and the PfEMP-1 protein, respectively.  Growth hormone-releasing peptides (GHRP) were identified as the first CD36 synthetic ligands. In order to identify new CD36 synthetic ligands, the development of a high-throughput method is essential to unveil compounds of high binding affinity. We have expressed a recombinant CD36 ectodomain protein in Sf9 insect cells. The soluble and affinity purified protein was immobilized on a surface plasmon resonance (SPR) sensor for binding studies. Synthetic ligands were analyzed by SPR spectroscopy for determination of their respective dissociation constant (KD). A structure-activity relationship of CD36 ligands was established. To validate the SPR binding signal, a good correlation was observed between KD and the IC50 values obtained from the inhibition curves of the MAPK kinase JNK1/2 phosphorylation induced by an oxidized phospholipid, the POVPC, in the presence of increasing concentrations of CD36 ligands in RAW 264.7 macrophage cells.
CD36 GHRP SPR Growth hormone-releasing peptides Surface plasmon resonance